CYAN
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.04 | $6M | $364,000 |
| 2026 Q4 | -0.02 | $8M | — |
| 2025 Q3 | -0.03 | $6M | — |
| 2025 Q2 | 0.00 | $7M | $44,000 |
| 2025 Q1 | -0.13 | $6M | -$350,000 |
| 2025 Q4 | -0.09 | $6M | -$141,000 |
| 2024 Q3 | -0.03 | $6M | -$993,000 |
| 2024 Q2 | -0.16 | $6M | -$397,000 |